FIELD: pharmacology; medicine.
SUBSTANCE: invention relates to a pharmaceutical composition for treating and/or preventing colitis. A pharmaceutical composition for treating and/or preventing colitis, containing 0.5 g of 5-pentylresorcinol with a purity of not less than 98%, 1.0 g of pharmaceutical starch and water for injections up to 100 g.
EFFECT: said invention is effective in treating and/or preventing ulcerative colitis.
1 cl, 10 dwg, 4 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| PHARMACEUTICAL COMPOSITION BASED ON 5-PENTYLRESORCINOL WITH HYPOGLYCEMIC EFFECT AND BODY WEIGHT REDUCTION EFFECT | 2023 |
|
RU2829635C1 |
| USE OF 5-PENTADECYLRESORCINOL TO INCREASE PROPORTION OF AKKERMANSIA MUCINIPHILA IN HUMAN MICROBIOME | 2023 |
|
RU2807743C1 |
| PHARMACEUTICAL COMPOSITION CONTAINING NICOTINIC ACID AND/OR NICOTINAMIDE AND/OR TRYPTOPHAN FOR POSITIVELY INFLUENCING THE INTESTINAL MICROBIOTA | 2013 |
|
RU2657797C2 |
| USE OF MICROBIAL COMMUNITIES FOR THE TREATMENT OF HUMANS AND ANIMALS | 2017 |
|
RU2758387C2 |
| USE OF MICROBIAL COMMUNITIES FOR TREATING HUMANS AND ANIMALS | 2017 |
|
RU2823233C2 |
| MELATONIN AGENT FOR TREATING INFLAMMATORY BOWEL DISEASES IN THE FORM OF RECTAL SUPPOSITORIES | 2023 |
|
RU2819721C1 |
| NOVEL PROSTAGLANDIN I DERIVATIVE | 2009 |
|
RU2509768C2 |
| ANTI-INFLAMMATORY PHARMACEUTICAL COMPOSITIONS BASED ON BACTERIAL STRAIN | 2015 |
|
RU2616899C1 |
| COMPOSITIONS AND METHODS OF THE TREATMENT OF INFLAMMATORY DISEASES OF THE INTESTINE | 2019 |
|
RU2799556C2 |
| NEW EP4 AGONIST | 2011 |
|
RU2564414C2 |
